Aryl hydrocarbon receptor activation by imidacloprid as a promoter of HER2(+) breast cancer progression: In silico, in vitro and in vivo studies.
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →